Inducible glomerular erythropoietin production in the adult kidney

Kidney International

Volumn 88, Issue 6, 2015, Pages 1345-1355

  Gerl, Katharina ^a   Miquerol, Lucile ^b   Todorov, Vladimir T ^c   Hugo, Christian P M ^c   Adams, Ralf H ^d   Kurtz, Armin ^a   Kurt, Birgül ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b AIX MARSEILLE UNIVERSITY   (France)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cell transformation; Erythropoietin; Glomerular cells; Renin; Von Hippel Lindau

Indexed keywords

CONNEXIN 40; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 2; MESSENGER RNA; RENIN; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SPECIFICITY; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENDOTHELIUM CELL; GENE DELETION; GENE EXPRESSION; GLOMERULUS; HEMATOCRIT; JUXTAGLOMERULAR CELL; KIDNEY DEVELOPMENT; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; VON HIPPEL LINDAU GENE;

EID: 84951567699     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.274     Document Type: Article

References (70)

1. Rankin EB, Biju MP, Liu Q et al. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 2007; 117: 1068-1077
2. Weidemann A, Kerdiles YM, Knaup KX et al. The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice. J Clin Invest 2009; 119: 3373-3383
3. Rankin EB, Wu C, Khatri R et al. The HIF signaling pathway in osteoblasts directly modulates erythropoiesis through the production of EPO. Cell 2012; 149: 63-74
4. Beirao I, Moreira L, Barandela T et al. Erythropoietin production by distal nephron in normal and familial amyloidotic adult human kidneys. Clin Nephrol 2010; 74: 327-335
5. Mujais SK, Beru N, Pullman TN et al. Erythropoietin is produced by tubular cells of the rat kidney. Cell Biochem Biophys 1999; 30: 153-166
6. Nagai T, Yasuoka Y, Izumi Y et al. Reevaluation of erythropoietin production by the nephron. Biochem Biophys Res Commun 2014; 449: 222-228
7. Koury ST, Bondurant MC, Koury MJ. Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. Blood 1988; 71: 524-527
8. Bachmann S, Le Hir M, Eckardt KU. Co-localization of erythropoietin mRNA and ecto-5'-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 1993; 41: 335-341
9. Maxwell PH, Osmond MK, Pugh CW et al. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 1993; 44: 1149-1162
10. Pan X, Suzuki N, Hirano I et al. Isolation and characterization of renal erythropoietin-producing cells from genetically produced anemia mice. PLoS One 2011; 6: e25839
11. Asada N, Takase M, Nakamura J et al. Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J Clin Invest 2011; 121: 3981-3990
12. Obara N, Suzuki N, Kim K et al. Repression via the GATA box is essential for tissue-specific erythropoietin gene expression. Blood 2008; 111: 5223-5232
13. Paliege A, Rosenberger C, Bondke A et al. Hypoxia-inducible factor-2alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization. Kidney Int 2010; 77: 312-318
14. Souma T, Yamazaki S, Moriguchi T et al. Plasticity of renal erythropoietinproducing cells governs fibrosis. J Am Soc Nephrol 2013; 24: 1599-1616
15. Eddy AA. Progression in chronic kidney disease. Adv Chronic Kidney Dis 2005; 12: 353-365
16. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006; 69: 213-217
17. Kapitsinou PP, Liu Q, Unger TL et al. Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. Blood 2010; 116: 3039-3048
18. Scortegagna M, Morris MA, Oktay Y et al. The HIF family member EPAS1/HIF-2alpha is required for normal hematopoiesis in mice. Blood 2003; 102: 1634-1640
19. Gruber M, Hu CJ, Johnson RS et al. Acute postnatal ablation of Hif-2alpha results in anemia. Proc Natl Acad Sci USA 2007; 104: 2301-2306
20. Jaakkola P, Mole DR, Tian YM et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468-472
21. Ivan M, Kondo K, Yang H et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292: 464-468
22. Bernhardt WM, Wiesener MS, Scigalla P et al. Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J Am Soc Nephrol 2010; 21: 2151-2156
23. Eckardt KU, Drueke T, Leski M et al. Unutilized reserves: the production capacity for erythropoietin appears to be conserved in chronic renal disease. Contrib Nephrol 1991; 88: 18-31 discussion 32-14
24. Kurt B, Paliege A, Willam C et al. Deletion of von Hippel-Lindau protein converts renin-producing cells into erythropoietin-producing cells. J Am Soc Nephrol 2013; 24: 433-444
25. Ema M, Taya S, Yokotani N et al. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 1997; 94: 4273-4278
26. Flamme I, Frohlich T, von Reutern M et al. HRF, a putative basic helix-loophelix-PAS-domain transcription factor is closely related to hypoxiainducible factor-1 alpha and developmentally expressed in blood vessels. Mech Dev 1997; 63: 51-60
27. Jain S, Maltepe E, Lu MM et al. Expression of ARNT, ARNT2, HIF1 alpha, HIF2 alpha and Ah receptor mRNAs in the developing mouse. Mech Dev 1998; 73: 117-123
28. Tian H, McKnight SL, Russell DW. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 1997; 11: 72-82
29. Wiesener MS, Jurgensen JS, Rosenberger C et al. Widespread hypoxiainducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J 2003; 17: 271-273
30. Kurt B, Gerl K, Karger C et al. Chronic hypoxia-inducible transcription factor-2 activation stably transforms juxtaglomerular renin cells into fibroblast-like cells in vivo. J Am Soc Nephrol 2015; 26: 587-596
31. Maxwell PH, Wiesener MS, Chang GW et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-275
32. Fang HY, Hughes R, Murdoch C et al. Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 2009; 114: 844-859
33. Bensellam M, Duvillie B, Rybachuk G et al. Glucose-induced O(2) consumption activates hypoxia inducible factors 1 and 2 in rat insulinsecreting pancreatic beta-cells. PLoS One 2012; 7: e29807
34. Suzuki K, Nishi K, Takabuchi S et al. Differential roles of prostaglandin E-type receptors in activation of hypoxia-inducible factor 1 by prostaglandin E1 in vascular-derived cells under non-hypoxic conditions. PeerJ 2013; 1: e220
35. Takeda N, Maemura K, Imai Y et al. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1. Circ Res 2004; 95: 146-153
36. Xue X, Shah YM. Hypoxia-inducible factor-2alpha is essential in activating the COX2/mPGES-1/PGE2 signaling axis in colon cancer. Carcinogenesis 2013; 34: 163-169
37. Olechnowicz SW, Fedele AO, Peet DJ. Hypoxic induction of the regulator of G-protein signalling 4 gene is mediated by the hypoxia-inducible factor pathway. PLoS One 2012; 7: e44564
38. Fujita N, Markova D, Anderson DG et al. Expression of prolyl hydroxylases (PHDs) is selectively controlled by HIF-1 and HIF-2 proteins in nucleus pulposus cells of the intervertebral disc: distinct roles of PHD2 and PHD3 proteins in controlling HIF-1alpha activity in hypoxia. J Biol Chem 2012; 287: 16975-16986
39. Aprelikova O, Chandramouli GV, Wood M et al. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. J Cell Biochem 2004; 92: 491-501
40. Rankin EB, Rha J, Selak MA et al. Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol Cell Biol 2009; 29: 4527-4538
41. Hartner A, Schocklmann H, Prols F et al. Alpha8 integrin in glomerular mesangial cells and in experimental glomerulonephritis. Kidney Int 1999; 56: 1468-1480
42. Starke C, Betz H, Hickmann L et al. Renin Lineage Cells Repopulate the Glomerular Mesangium after Injury. J Am Soc Nephrol 2014; 26: 48-54
43. Lindahl P, Hellstrom M, Kalen M et al. Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development 1998; 125: 3313-3322
44. Kurtz L, Madsen K, Kurt B et al. High-level connexin expression in the human juxtaglomerular apparatus. Nephron Physiol 2010; 116: p1-p8
45. Wong CY, Cheong SK, Mok PL et al. Differentiation of human mesenchymal stem cells into mesangial cells in post-glomerular injury murine model. Pathology 2008; 40: 52-57
46. Humphreys BD. Targeting pericyte differentiation as a strategy to modulate kidney fibrosis in diabetic nephropathy. Semin Nephrol 2012; 32: 463-470
47. Kida Y, Duffield JS. Pivotal role of pericytes in kidney fibrosis. Clin Exp Pharmacol Physiol 2011; 38: 467-473
48. Morioka T, Okada S, Nameta M et al. Glomerular expression of connexin 40 and connexin 43 in rat experimental glomerulonephritis. Clin Exp Nephrol 2013; 17: 191-204
49. Brunskill EW, Sequeira-Lopez ML, Pentz ES et al. Genes that confer the identity of the renin cell. J Am Soc Nephrol 2011; 22: 2213-2225
50. Castellanos-Rivera RM, Pentz ES, Lin E et al. Recombination signal binding protein for Ig-kappaJ region regulates juxtaglomerular cell phenotype by activating the Myo-endocrine program and suppressing ectopic gene expression. J Am Soc Nephrol 2014; 26: 67-80
51. Hwan Seul K, Beyer EC. Heterogeneous localization of connexin40 in the renal vasculature. Microvasc Res 2000; 59: 140-148
52. Schley G, Klanke B, Schodel J et al. Hypoxia-inducible transcription factors stabilization in the thick ascending limb protects against ischemic acute kidney injury. J Am Soc Nephrol 2011; 22: 2004-2015
53. Rankin EB, Tomaszewski JE, Haase VH. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Cancer Res 2006; 66: 2576-2583
54. Mathia S, Paliege A, Koesters R et al. Action of hypoxia-inducible factor in liver and kidney from mice with Pax8-rtTA-based deletion of von Hippel-Lindau protein. Acta Physiol (Oxf) 2013; 207: 565-576
55. Ding M, Cui S, Li C et al. Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice. Nat Med 2006; 12: 1081-1087
56. Nishikimi T. Adrenomedullin in the kidney-renal physiological and pathophysiological roles. Curr Med Chem 2007; 14: 1689-1699
57. Nasrallah R, Hebert RL. Prostacyclin signaling in the kidney: implications for health and disease. Am J Physiol Renal Physiol 2005; 289: F235-F246
58. Gu S, Cifelli C, Wang S et al. RGS proteins: identifying new GAPs in the understanding of blood pressure regulation and cardiovascular function. Clin Sci 2009; 116: 391-399
59. Sweet RL, Zastre JA. HIF1-alpha-mediated gene expression induced by vitamin B1 deficiency. Int J Vitam Nutr Res 2013; 83: 188-197
60. Agani F, Jiang BH. Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer. Curr Cancer Drug Targets 2013; 13: 245-251
61. Diebold I, Flugel D, Becht S et al. The hypoxia-inducible factor-2alpha is stabilized by oxidative stress involving NOX4. Antioxid Redox Signal 2010; 13: 425-436
62. Han X, Sun S, Zhao M et al. Celastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS/Akt/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1alpha protein synthesis. PLoS One 2014; 9: e112470
63. Laughner E, Taghavi P, Chiles K et al. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001; 21: 3995-4004
64. Pan Y, Mansfield KD, Bertozzi CC et al. Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Mol Cell Biol 2007; 27: 912-925
65. Haase VH, Glickman JN, Socolovsky M et al. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc Natl Acad Sci USA 2001; 98: 1583-1588
66. Beyer S, Kelly RG, Miquerol L. Inducible Cx40-Cre expression in the cardiac conduction system and arterial endothelial cells. Genesis 2011; 49: 83-91
67. Schonig K, Schwenk F, Rajewsky K et al. Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res 2002; 30: e134
68. Monvoisin A, Alva JA, Hofmann JJ et al. VE-cadherin-CreERT2 transgenic mouse: a model for inducible recombination in the endothelium. Dev Dyn 2006; 235: 3413-3422
69. Muzumdar MD, Tasic B, Miyamichi K et al. A global double-fluorescent cre reporter mouse. Genesis 2007; 45: 593-605
70. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.